Product Information

SANDOSTATIN LAR DEPOT 30 MG KT is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $6948.0840 per EA under NDC 00078082581. Its NADAC has been published 53 times since Aug 20, 2025.

FDA first approved this application on Nov 25, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the octreotide acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for SANDOSTATIN LAR DEPOT 30 MG KT has been published 53 times since Aug 20, 2025, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.